Breast Cancer, a Global Health Crisis
DOI:
https://doi.org/10.63053/ijhes.23Abstract
Breast cancer is still a public health problem worldwide and is currently the most common tumor in the world. Breast cancer is a life-threatening disease in women and the leading cause of death in the female population. Breast cancer is a heterogeneous disorder with different molecular subtypes and biological characteristics, with different therapeutic functions and clinical outcomes for each molecular subtype. Furthermore, the treatment of BC is complicated by intratumoral complexity. Consequently, breast cancer risk assessment is an important part of public health. Precision medicine for breast cancer is a practice for diagnosis, treatment, screening and prevention of the disease that takes into account the patient's genetic makeup. Therefore, by identifying women who are at high risk of breast cancer, it is possible to make personalized recommendations regarding screening methods, the age at which breast screening should begin, the frequency of completing screenings, and individual counselling.
References
- Zhu JW, Charkhchi P, Adekunte S, Akbari MR. What Is Known about Breast Cancer in Young Women? Cancers (Basel). 2023 Mar 22;15(6):1917. doi: 10.3390/cancers15061917. PMID: 36980802; PMCID: PMC10047861.
- Basmadjian RB, Chow K, Kim D, Kenney M, Lukmanji A, O'Sullivan DE, Xu Y, Quan ML, Cheung WY, Lupichuk S, Brenner DR. The Association between Early-Onset Diagnosis and Clinical Outcomes in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel). 2023 Mar 23;15(7):1923. doi: 10.3390/cancers15071923. PMID: 37046584; PMCID: PMC10093252.
- Hipp LE, Hulswit BB, Milliron KJ. Clinical tools and counseling considerations for breast cancer risk assessment and evaluation for hereditary cancer risk. Best Pract Res Clin Obstet Gynaecol. 2022 Jun;82:12-29. Doi: 10.1016/j.bpobgyn.2022.02.001. Epub 2022 Feb 9. PMID: 35256281.
- Johnson RH, Anders CK, Litton JK, Ruddy KJ, Bleyer A. Breast cancer In adolescents and young adults. Pediatr Blood Cancer. 2018 Dec;65(12):e27397. doi: 10.1002/pbc.27397. Epub 2018 Aug 28. PMID: 30156052; PMCID: PMC6192832.
- Polivka J Jr, Altun I, Golubnitschaja O. Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine. EPMA J. 2018 Feb 8;9(1):1-13. Doi: 10.1007/s13167-018-0129-7. PMID: 29515683; PMCID: PMC5833893.
- Durrani S, Akbar S, Heena H. Breast Cancer During Pregnancy. Cureus. 2018 Jul 8;10(7):e2941. doi: 10.7759/cureus.2941. PMID: 30202672; PMCID: PMC6128597.
- Margioula-Siarkou G, Margioula-Siarkou C, Petousis S, Vavoulidis E, Margaritis K, Almperis A, Haitoglou C, Mavromatidis G, Dinas K. Breast Carcinogenesis during Pregnancy: Molecular Mechanisms, Maternal and Fetal Adverse Outcomes. Biology (Basel). 2023 Mar 6;12(3):408. doi: 10.3390/biology12030408. PMID: 36979100; PMCID: PMC10045536.
- Maggen C, Wolters VERA, Cardonick E, Fumagalli M, Halaska MJ, Lok CAR, de Haan J, Van Tornout K, Van Calsteren K, Amant F; International Network on Cancer, Infertility and Pregnancy (INCIP). Pregnancy and Cancer: the INCIP Project. Curr Oncol Rep. 2020 Feb 5;22(2):17. doi: 10.1007/s11912-020-0862-7. PMID: 32025953; PMCID: PMC7002463.
- Alfasi A, Ben-Aharon I. Breast Cancer during Pregnancy-Current Paradigms, Paths to Explore. Cancers (Basel). 2019 Oct 28;11(11):1669. doi: 10.3390/cancers11111669. PMID: 31661803; PMCID: PMC6896197.
- Ramesh P, Srikumar S, Mahendran V, Nair SS, Radhamany K. Pregnancy-Associated Breast Cancer: A Realistic Approach. J Obstet Gynaecol India. 2019 Dec;69(6):514-519. Doi: 10.1007/s13224-019-01249-9. Epub 2019 Jul 18. PMID: 31844366; PMCID: PMC6888785.
- Fiaz T, Nadeem MS, Afzal O, Altamimi ASA, Alzarea SI, Almalki WH, Khan HA, Iahtisham-Ul-Haq, Hanook S, Kazmi I, Mustafa M. Peripheral mRNA Expression and Prognostic Significance of Emotional Stress Biomarkers in Metastatic Breast Cancer Patients. Int J Mol Sci. 2022 Nov 15;23(22):14097. doi: 10.3390/ijms232214097. PMID: 36430579; PMCID: PMC9694977.
- Peng H, Zhu Y, Strachan E, Fowler E, Bacus T, Roy-Byrne P, Goldberg J, Vaccarino V, Zhao J. Childhood Trauma, DNA Methylation of Stress-Related Genes, and Depression: Findings From Two Monozygotic Twin Studies. Psychosom Med. 2018 Sep;80(7):599-608. Doi: 10.1097/PSY.0000000000000604. PMID: 29781947; PMCID: PMC6113110.
- Liu Y, Song J, Gu J, Xu S, Wang X, Liu Y. The Role of BTBD7 in Normal Development and Tumor Progression. Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231167732. doi: 10.1177/15330338231167732. PMID: 37050886; PMCID: PMC10102955.
- Li L, Guturi KKN, Gautreau B, Patel PS, Saad A, Morii M, Mateo F, Palomero L, Barbour H, Gomez A, Ng D, Kotlyar M, Pastrello C, Jackson HW, Khokha R, Jurisica I, Affar EB, Raught B, Sanchez O, Alaoui-Jamali M, Pujana MA, Hakem A, Hakem R. Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis. J Clin Invest. 2018 Oct 1;128(10):4525-4542. Doi: 10.1172/JCI120401. Epub 2018 Aug 2. Erratum In: J Clin Invest. 2021 Jul 1;131(13): PMID: 30222135; PMCID: PMC6160000.
- Namee NM, O 'Driscoll L. Extracellular vesicles and anti-cancer drug resistance. Biochim Biophys Acta Rev Cancer. 2018 Dec;1870(2):123-136. Doi: 10.1016/j.bbcan.2018.07.003. Epub 2018 Jul 10. PMID: 30003999.
- Wang B, Wang Y, Wang X, Gu J, Wu W, Wu H, Wang Q, Zhou D. Extracellular Vesicles Carrying miR-887-3p Promote Breast Cancer Cell Drug Resistance by Targeting BTBD7 and Activating the Notch1/Hes1 Signaling Pathway. Dis Markers. 2022 May 23;2022:5762686. Doi: 10.1155/2022/5762686. PMID: 35655918; PMCID: PMC9152417.
- Albi E, Mandarano M, Cataldi S, Ceccarini MR, Fiorani F , Beccari T, Sidoni A, Codini M. The Effect of Cholesterol in MCF7 Human Breast Cancer Cells. Int J Mol Sci. 2023 Mar 21;24(6):5935. Doi: 10.3390/ijms24065935. PMID: 36983016; PMCID: PMC10052157.
- Kudela E, Samec M, Kubatka P, Nachajova M, Laucekova Z, Liskova A, Dokus K, Biringer K, Simova D, Gabonova E, Dankova Z, Biskupska Bodova K, Zubor P, Trog D. Breast Cancer in Young Women: Status Quo and Advanced Disease Management by a Predictive, Preventive, and Personalized Approach. Cancers (Basel). 2019 Nov 14;11(11):1791. doi: 10.3390/cancers11111791. PMID: 31739537; PMCID: PMC6896106.
- Monticciolo DL, Newell MS, Moy L, Niell B, Monsees B, Sickles EA. Breast Cancer Screening in Women at Higher -Than-Average Risk: Recommendations From the ACR. J Am Coll Radiol. 2018 Mar;15(3 Pt A):408-414. Doi: 10.1016/j.jacr.2017.11.034. Epub 2018 Jan 19. PMID: 29371086.
- Freitas AJA, Causin RL, Varuzza MB, Calfa S , Hidalgo Filho CMT, Komoto TT, Souza CP, Marques MMC. Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer. Int J Mol Sci. 2022 Sep 1;23(17):9952. doi: 10.3390/ijms23179952. PMID: 36077348; PMCID: PMC9456236.
- Di Cosimo S, Appierto V, Pizzamiglio S, Silvestri M, Baselga J, Piccart M, Huober J, Izquierdo M, de la Pena L, Hilbers FS, de Azambuja E, Untch M, Pusztai L, Pritchard K, Nuciforo P, Vincent-Salomon A, Symmans F, Apolone G, de Braud FG, Iorio MV, Verderio P, Daidone MG. Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy. Int J Mol Sci. 2020 Feb 18;21(4):1386. doi: 10.3390/ijms21041386. PMID: 32085669; PMCID: PMC7073028.
- Bovy N, Blomme B, Frères P, Dederen S, Nivelles O , Lion M, Carnet O, Martial JA, Noël A, Thiry M, Jérusalem G, Josse C, Bours V, Tabruyn SP, Struman I. Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer. Oncotarget. 2015 Apr 30;6(12):10253-66. Doi: 10.18632/oncotarget.3520. PMID: 25860935; PMCID: PMC4496353.
- O'Leary B, Hrebien S, Morden JP, Beaney M, Fribbens C, Huang X, Liu Y, Bartlett CH, Koehler M, Cristofanilli M, Garcia-Murillas I, Bliss JM, Turner NC. Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer. Nat Commun. 2018 Mar 1;9(1):896. doi: 10.1038/s41467-018-03215-x. PMID: 29497091; PMCID: PMC5832789.
- Derakhshan F, Reis-Filho JS. Pathogenesis of Triple-Negative Breast Cancer. Annu Rev Pathol. 2022 Jan 24;17:181-204. Doi: 10.1146/annurev-pathol-042420-093238. PMID: 35073169; PMCID: PMC9231507.
- Kumar P, Aggarwal R. An overview of triple-negative breast cancer. Arch Gynecol Obstet. 2016 Feb;293(2):247-69 . Doi: 10.1007/s00404-015-3859-y. Epub 2015 Sep 4. PMID: 26341644.
- Kwapisz D. Pembrolizumab and atezolizumab in triple-negative breast cancer. Cancer Immunol Immunother. 2021 Mar;70(3):607-617. Doi: 10.1007/s00262-020-02736-z. Epub 2020 Oct 5. PMID: 33015734.
- Zhang H, Yang F, Xiao Y, Jiang Y, Shao Z. Conceptualizing the complexity of ferroptosis to treat triple-negative breast cancer: theory-to-practice. Cancer Biol Med. 2023 Mar 2;20(2):98–103. Doi: 10.20892/j.issn.2095-3941.2022.0767 . PMID: 36861444; PMCID: PMC9978894.
- Yang F, Xiao Y, Ding JH, Jin X, Ma D , Li DQ, Shi JX, Huang W, Wang YP, Jiang YZ, Shao ZM. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell Metab. 2023 Jan 3;35(1):84-100.e8. doi: 10.1016/j.cmet.2022.09.021. Epub 2022 Oct 17. PMID: 36257316.
- Miglietta F, Bottosso M, Griguolo G, Dieci MV, Guarneri V. Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival. ESMO Open. 2022 Apr;7(2):100409. doi: 10.1016/j.esmoop.2022.100409. Epub 2022 Feb 26. Erratum in: ESMO Open. 2022 Apr 7;7(3):100472. PMID: 35227965; PMCID: PMC8886005.
- Al-Mahmood S, Sapiezynski J, Garbuzenko OB, Minko T. Metastatic and triple-negative breast cancer: challenges and treatment options. Drug Deliv Transl Res. 2018 Oct;8(5):1483-1507. doi: 10.1007/s13346-018-0551-3. PMID: 29978332; PMCID: PMC6133085.
- Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT, Zackrisson S, Senkus E; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann Oncol. 2019 Aug 1;30(8):1194-1220. Doi: 10.1093/annonc/mdz173. Erratum in: Ann Oncol. 2019 Oct 1;30(10):1674. Erratum in: Ann Oncol. 2021 Feb;32(2):284. PMID: 31161190.
- Ren W, Chen M, Qiao Y, Zhao F. Global guidelines for breast cancer screening: A systematic review. Breast. 2022 Aug;64:85-99. Doi: 10.1016/j.breast.2022.04.003. Epub 2022 Apr 19. PMID: 35636342; PMCID: PMC9142711.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
The journal is licensed under a Attribution 4.0 International (CC BY 4.0).
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution - You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions - You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
